HomeCompareBKDV vs JNJ

BKDV vs JNJ: Dividend Comparison 2026

BKDV yields 0.60% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BKDV wins by $499.00 in total portfolio value
10 years
BKDV
BKDV
● Live price
0.60%
Share price
$29.66
Annual div
$0.18
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.5K
Annual income
$62.76
Full BKDV calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BKDV vs JNJ

📍 BKDV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBKDVJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BKDV + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BKDV pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BKDV
Annual income on $10K today (after 15% tax)
$51.30/yr
After 10yr DRIP, annual income (after tax)
$53.35/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $650.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BKDV + JNJ for your $10,000?

BKDV: 50%JNJ: 50%
100% JNJ50/50100% BKDV
Portfolio after 10yr
$20.3K
Annual income
$445.27/yr
Blended yield
2.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BKDV
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BKDV buys
0
JNJ buys
0
No recent congressional trades found for BKDV or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBKDVJNJ
Forward yield0.60%3.36%
Annual dividend / share$0.18$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.5K$20.0K
Annual income after 10y$62.76$827.78
Total dividends collected$617.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BKDV vs JNJ ($10,000, DRIP)

YearBKDV PortfolioBKDV Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,760$60.35$10,676$355.77+$84.00BKDV
2$11,574$60.69$11,407$389.39+$167.00BKDV
3$12,445$61.01$12,198$426.53+$247.00BKDV
4$13,378$61.31$13,056$467.62+$322.00BKDV
5$14,376$61.59$13,987$513.12+$389.00BKDV
6$15,444$61.86$14,998$563.56+$446.00BKDV
7$16,587$62.10$16,098$619.52+$489.00BKDV
8$17,811$62.34$17,295$681.69+$516.00BKDV
9$19,120$62.56$18,599$750.82+$521.00BKDV
10$20,521$62.76$20,022$827.78+$499.00BKDV

BKDV vs JNJ: Complete Analysis 2026

BKDVStock

The fund seeks capital appreciation by investing primarily in value stocks — stocks that are included in at least one of the Russell 3000 Value Index, the S&P Composite 1500 Value Index or the MSCI ACWI Value Index, or a company that has a lower price-to-book ratio than the S&P 500 Index. The fund's managers look to identify companies with attractive valuations, strong fundamentals and catalyst-driven business momentum. The fund can invest in companies of any size, but generally focuses on the stocks of large capitalization companies. Liquid ETF structure allows investors to buy or sell any time the market is open.

Full BKDV Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BKDV vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BKDV vs SCHDBKDV vs JEPIBKDV vs OBKDV vs KOBKDV vs MAINBKDV vs ABBVBKDV vs MRKBKDV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.